[Unconventional therapeutic methods in superficial bladder cancer]

Area of Science:

• Urology
• Immunotherapy
• Oncology

Background:

• Superficial bladder cancer requires effective recurrence prophylaxis.
• Bacillus Calmette-Guérin (BCG) is a standard treatment, but novel agents are being explored.
• Keyhole limpet hemocyanin (KLH) demonstrates immunomodulatory effects in preclinical models.

Purpose of the Study:

• To evaluate the potential of unconventional agents for superficial bladder cancer recurrence prophylaxis.
• To assess the clinical role of KLH in comparison to established treatments.
• To investigate the efficacy of other novel approaches like mistletoe extracts and vitamin supplementation.

Main Methods:

• Review of existing clinical data on KLH for bladder cancer.
• Discussion of the need for prospective, randomized trials with standardized protocols for KLH.
• Exploration of preliminary findings on mistletoe extracts, iontophoresis, and vitamin therapies.

Main Results:

• Preclinical studies suggest KLH has efficacy comparable to BCG, increasing natural killer cell activity.
• Clinical data on KLH are limited and contradictory.
• Vitamin A and multivitamins combined with BCG show a significant decrease in recurrence rates, though optimal formulations and mechanisms remain unclear.

Conclusions:

• The definitive clinical role of KLH in superficial bladder cancer prophylaxis requires large-scale, prospective randomized studies.
• Mistletoe extracts and intravesical antineoplastic iontophoresis lack sufficient evidence for recurrence prevention.
• Vitamin supplementation alongside BCG shows potential, but further research is needed to identify optimal regimens and elucidate mechanisms.